Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Nuwellis, Inc. stock logo
CHFS
Nuwellis
$0.92
-1.6%
$4.79
$4.86
$37.50
$5.52M1.55467,323 shs36,605 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$2.73
-4.5%
$2.22
$1.33
$6.20
$19.70M3.34406,728 shs174,535 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.20
+0.8%
$1.59
$0.53
$4.49
$20.60M4.671.24 million shs85,136 shs
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$0.79
+2.4%
$0.70
$0.35
$0.86
$21.44M-0.2157,476 shs2,078 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Nuwellis, Inc. stock logo
CHFS
Nuwellis
+4.44%+3.33%-2.11%-23.77%+227.70%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
+2.14%-5.61%+26.77%+31.19%-12.80%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.00%-1.65%-34.62%-56.09%+78.95%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-3.62%-3.60%+2.46%+35.30%-5.26%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/AN/AN/AN/AN/AN/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/AN/AN/AN/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.4045 of 5 stars
3.55.00.00.03.33.30.0
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.00
N/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
0.00
N/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00316.98% Upside
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest CHFS, QTI, NRXS, and NXL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/24/2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$5.00
(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Nuwellis, Inc. stock logo
CHFS
Nuwellis
$5.51M1.00N/AN/A$12.79 per share0.07
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$2.93M6.71N/AN/A($0.27) per share-10.11
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$131.07K157.16N/AN/A$0.43 per share2.79
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$4.00M5.36N/AN/A($1.91) per share-0.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Nuwellis, Inc. stock logo
CHFS
Nuwellis
-$18.11M-$279.28N/AN/AN/A-254.26%-173.61%-131.01%N/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-$14.63M-$1.19N/AN/A-492.76%N/A-641.25%N/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$4.65M-$0.83N/AN/A-3,407.98%-187.59%-167.21%N/A
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-$4.03MN/A0.00N/AN/AN/A-65.94%8/6/2025 (Estimated)

Latest CHFS, QTI, NRXS, and NXL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
3/14/2025Q4 2024
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A-$0.28N/A-$0.28N/A$0.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/AN/AN/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Nuwellis, Inc. stock logo
CHFS
Nuwellis
N/A
6.87
5.97
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/A
0.24
0.23
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
16.42
15.89
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/A
1.06
0.48

Institutional Ownership

CompanyInstitutional Ownership
Nuwellis, Inc. stock logo
CHFS
Nuwellis
65.06%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
11.77%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
24.19%

Insider Ownership

CompanyInsider Ownership
Nuwellis, Inc. stock logo
CHFS
Nuwellis
0.60%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
26.40%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
24.00%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
75.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Nuwellis, Inc. stock logo
CHFS
Nuwellis
666.04 millionN/ANot Optionable
NeurAxis, Inc. stock logo
NRXS
NeurAxis
197.22 million6.09 millionNot Optionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.18 million10.11 millionNot Optionable
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/A27.13 million6.68 millionN/A

Recent News About These Companies

QT Imaging (NASDAQ:QTI) Stock Price Down 2.9% - Here's Why

New MarketBeat Followers Over Time

Media Sentiment Over Time

Nuwellis stock logo

Nuwellis NASDAQ:CHFS

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

NeurAxis stock logo

NeurAxis NASDAQ:NRXS

$2.73 -0.13 (-4.55%)
Closing price 04:00 PM Eastern
Extended Trading
$2.75 +0.02 (+0.73%)
As of 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.20 +0.01 (+0.76%)
Closing price 04:00 PM Eastern
Extended Trading
$1.27 +0.07 (+6.25%)
As of 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

QT Imaging stock logo

QT Imaging NASDAQ:QTI

$0.79 +0.02 (+2.44%)
As of 05/29/2025

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.